Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 23 images provide visual information about the product associated with Gabapentin NDC 50228-178 by Sciegen Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Gabapentin Capsules are a medication with each capsule containing 100 mg USP of gabapentin. The user must read the accompanying prescribing information for usual dosage. It is advised to store the capsules in a Temperature range of 20° to 25°C (68° to 77°, with permitted excursions of 15° to 30°C (59° to 86°F) and a tight container with a child-resistant closure. Also, ensure to keep the capsules out of the reach of children. The medication is manufactured by Scieten Pramaceuticas, c., Hauppauge, NY 11788, and comes with 30 capsules for prescription only. The pharmacist has to provide a medication guide to each patient when dispensing Gabapentin Capsules. The Lot number is X with NDC 50228-179-30.*
Gabapentin Capsules are available in a bottle of 1000 capsules, with each capsule containing 100mg of the medication. The NDC (National Drug Code) is 50228-179-10. This medication is only available with a prescription from a healthcare provider. The packaging includes a medication guide from the manufacturer or pharmacy.*
This is a description of medication for Gabapentin Capsules, USP. It comes in a package of 100 capsules with NDC 50228-179-01. It also includes instructions and information for the pharmacists to provide the medication with a valid prescription only. The rest of the text seems to be not-available, as it contains non-English characters.*
Gabapentin Capsules, USP is a medication available in capsule form, with each capsule containing 300 mg of gabapentin, USP. The usual dosage can be found in the accompanying prescribing information. This medication should be stored at 20° to 25°C (68° to 77°F) and can be stored temporarily at 15° to 30°C (69° to 86°F). Dispense in a tight container with a child-resistant closure and keep out of reach of children. The medication guide should be provided to each patient when dispensing. This medication was manufactured by ScieGen Pharmaceuticals in Hauppauge, NY 11788.*
This is the label of a medication called Gabapentin, USP available in capsules form. It comes in a pack of 100 capsules and is a prescription-only medicine. The label also indicates that the pharmacist should provide a medication guide to the patients while dispensing.*
Gabapentin capsules are available in the strength of 400mg, USP. The usual dosage and prescribing information are available with the product, and it should be stored in a tightly closed container. It should be stored in a place at a room temperature of 20°-25°C (68°-77°F) with excursions permitted between 15°-30°C (59°-86°F) as recommended by the USP. A medication guide should be provided to each patient by the pharmacist when dispensing Gabapentin capsules. The product is manufactured and issued by ScieGen Pharmaceuticals.*
This is a description of a medication called Gabapentin in tablet form. Each film-coated tablet contains 600mg of gabapentin. The typical dosage is not available and can be obtained from the prescribing information. The tablets should be stored at room temperature and protected from exposure to extreme temperatures. The medication should be dispensed in a child-proof container and kept away from children. This product was manufactured in Hauppauge, NY and contains 30 tablets. A Medication Guide should be provided to each patient when dispensing Gabapentin Tablets. This medication is available with a prescription.*
This is a prescription label for Gabapentin tablets, which is used to treat seizures in adults and children. The label mentions the strength and quantity of the tablets, and warns against driving after taking the medication. The label also includes the manufacturer, ScieGen, and the drug identification number. Additionally, there is a note to pharmacists to provide a medication guide to each patient when dispensing the tablets.*
Gabapentin is a drug that comes in a film-coated tablet form with 800 mg of USP quality. It has usual dosage details which are mentioned in the accompanying prescribing information. It should be stored at a temperature within 20° to 25°C or with excursions permitted between 15° to 30°C. The tablet needs to be dispensed in a tight container that has a child-resistant closure. This drug has an NDC code of 50228-178-30 and comes in a pack of 30 tablets that should be kept out of the reach of children. Additionally, when dispensed, the pharmacist must attach a medication guide for the patient. The manufacturer is identified as Scieten Pramaceuticaks, c. based in Hauppauge, NY 11788.*
This is a label for a medicine container of Gabapentin tablets, with 100 Tablets of 800mg strength. There is a Provident medication guide for patients when dispensing. The medicine is available only with a prescription.*
This appears to be a product label or prescription information for "Gabapen" tablets, which are for prescription only. The tablet contains a substance called "Gabapentin USP" and the label includes identifying information, such as NDC code 50228-178-05, which could be used to locate the medication. There is also other text on the label that appears to be related to dosage instructions and possibly manufacturer information.*
This is a table that shows the mean pain score for a study comparing different treatments for pain management. The study involved two groups, one with a titration period where the dosage of the medication was adjusted based on the patient's response, and another with a fixed dose. The treatments being compared were a placebo and gabapentin at a dosage of 3600 mg/day. The table only shows data for the baseline and weeks 0 and 4 of the study.*
This appears to be a chart displaying the results of a study where patients received either a placebo or Gabapentin at different dosages for a duration of three weeks. The chart shows the mean pain scores of the patients over the seven weeks of the study. The x-axis represents the weeks of the study, and the y-axis represents the mean pain score. However, without more context or information, it is difficult to determine the purpose or outcome of the study.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.